Company Filing History:
Years Active: 2012
Title: Christopher Farrell: Innovator in Cancer Immunotherapy
Introduction
Christopher Farrell is a notable inventor based in Brookline, MA (US). He has made significant contributions to the field of cancer treatment through his innovative research and patented methods. His work focuses on utilizing oncolytic herpes simplex virus immunotherapy to stimulate immune responses against brain cancer.
Latest Patents
Christopher Farrell holds a patent for a method of stimulating an immune response to treat cancer. This patent, titled "Oncolytic herpes simplex virus immunotherapy in the treatment of brain cancer," describes a composition that includes dendritic cells incubated with either oHSV-infected tumor cells or a composition derived from them. Additionally, it covers methods of preparing such compositions, which are crucial for advancing cancer treatment.
Career Highlights
Farrell is associated with The General Hospital Corporation, where he continues to work on groundbreaking research in immunotherapy. His dedication to improving cancer treatment has positioned him as a key figure in the medical research community.
Collaborations
Christopher Farrell collaborates with esteemed colleagues, including Robert L Martuza and Samuel D Rabkin. Their combined expertise enhances the research efforts in the field of cancer immunotherapy.
Conclusion
Christopher Farrell's innovative work in cancer treatment through immunotherapy exemplifies the impact of scientific research on healthcare. His contributions are paving the way for new therapeutic approaches to combat brain cancer effectively.